Organoid and microfluidics-based platforms for drug screening in COVID-19

Proposing efficient prophylactic and therapeutic strategies for coronavirus 2019 (COVID-19) requires precise knowledge of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogenesis. An array of platforms, including organoids and microfluidic devices, have provided a basis for studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramezankhani, Roya, Solhi, Roya, Chai, Yoke Chin, Vosough, Massoud, Verfaillie, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Foundation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695520/
https://www.ncbi.nlm.nih.gov/pubmed/34954328
http://dx.doi.org/10.1016/j.drudis.2021.12.014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695520/
https://www.ncbi.nlm.nih.gov/pubmed/34954328
http://dx.doi.org/10.1016/j.drudis.2021.12.014

Ejemplares similares